glp-1 masld The Emerging Role of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis Direct and indirect effects of

This stepwise escalation principle mirrors the approach used for licensed medicines such as semaglutide (Wegovy, UK SmPC available via the electronic Medicines Compendium) and tirzepatide (Mounjaro, UK SmPC available via the electronic Medicines Compendium), both of which are approved by the MHRA and recommended within relevant NICE guidance for specific indications

Monitoring progress regularly is critical

These more severe complications include gallbladder disease, kidney disease, allergic reactions, pancreatitis, and thyroid cancer

Published data from TRIUMPH-1 and TRIUMPH-4 show that discontinuation rates rise with dose